7Baggers
 Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells 500 Shares  MarketBeat Thu, 02 Oct 2025 22:37:52 GMT
 Amphastar Signs $2.8M Research Agreement with Hanxin  MSN Sat, 27 Sep 2025 01:06:06 GMT
 3 Low-Volatility Stocks with Open Questions  TradingView Wed, 24 Sep 2025 04:38:00 GMT
 amphastar signs $2.8m research agreement with hanxin  MSN Sun, 21 Sep 2025 00:49:27 GMT
 amphastar signs $2.8m research agreement with hanxin  TipRanks Fri, 19 Sep 2025 01:50:09 GMT
 Amphastar Signs $2.8M Research Agreement with Hanxin  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 amphastar at wells fargo conference: strategic growth in focus by investing.com  Investing.com Australia Fri, 05 Sep 2025 04:25:58 GMT
 how to contact the daily bulletin  FinancialContent Fri, 05 Sep 2025 03:32:00 GMT
 published on: 2025-09-04 06:16:29  خودرو بانک Thu, 04 Sep 2025 02:47:31 GMT
 published on: 2025-09-03 09:19:22  Newser Wed, 03 Sep 2025 14:19:22 GMT
 Amphastar at Wells Fargo Conference: Strategic Growth in Focus  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 04:47:08  Newser Tue, 02 Sep 2025 09:47:08 GMT
 published on: 2025-09-02 08:34:50  khodrobank.com Tue, 02 Sep 2025 05:05:46 GMT
 published on: 2025-09-01 11:27:34  Newser Mon, 01 Sep 2025 16:27:34 GMT
 published on: 2025-08-31 16:00:23  Newser Sun, 31 Aug 2025 21:00:23 GMT

Amphastar Pharmaceuticals, Inc
(NASDAQ:AMPH) 

AMPH stock logo

Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products...

Founded: 1996
Full Time Employees: 2,027
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends